Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30959771 | 1.00 | NLRP3 (0.41) | NLRP3ALDH1A1LMNAHSD17B10SMN1; SMN2 | |
| SCHEMBL7230011 | 1.00 | NLRP3 (0.41) | NLRP3ALDH1A1LMNAHSD17B10SMN1; SMN2 | |
| SCHEMBL13346537 | 0.93 | NLRP3 (0.37) | NLRP3ALDH1A1LMNAHSD17B10SMN1; SMN2 | |
| SCHEMBL13346554 | 0.89 | NLRP3 (0.36) | NLRP3ALDH1A1SMN1; SMN2CYP3A4CYP2C19 | |
| SCHEMBL1088791 | 0.89 | NLRP3 (0.37) | NLRP3ALDH1A1LMNAHSD17B10SMN1; SMN2 | |
| SCHEMBL1088512 | 0.87 | NLRP3 (0.36) | NLRP3ALDH1A1LMNAHSD17B10SMN1; SMN2 | |
| SCHEMBL13346552 | 0.87 | ALDH1A1 (0.39) | NLRP3ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL13346555 | 0.86 | CA12 (0.39) | NLRP3ALDH1A1LMNAHSD17B10CYP3A4 | |
| SCHEMBL1088471 | 0.84 | NLRP3 (0.35) | NLRP3 | |
| SCHEMBL13346574 | 0.83 | NLRP3 (0.36) | NLRP3ALDH1A1LMNAHSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371641-A | Cyclic olefin ring-opening polymer and hydride thereof | 杭州睿丰融创科技有限公司 | 2025-01-28 | — | — | CN | disclosed |
| WO-2023088919-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2023-05-25 | — | — | WO | disclosed |
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-07-14 | — | — | US | disclosed |
| US-20220161245-A1 | Compositions And Methods For Infrared-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-05-26 | — | — | US | disclosed |
| US-11331656-B2 | Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-05-17 | — | — | US | disclosed |
| US-9701704-B2 | Catalysts for (E)-selective olefin metathesis | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-07-11 | — | — | US | disclosed |
| US-9701704-B2 | Catalysts for (E)-selective olefin metathesis | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-07-11 | — | — | US | disclosed |
| EP-2634197-B1 | CATALYST FOR NORBORNENE MONOMER POLYMERIZATION AND METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO KK (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-20170104214-A1 | FUSED-RING QUINONE-SUBSTITUTED POLYNORBORNENE, ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | WASEDA UNIVERSITY (JP) | 2017-04-13 | — | — | US | disclosed |
| US-20170104214-A1 | FUSED-RING QUINONE-SUBSTITUTED POLYNORBORNENE, ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | WASEDA UNIVERSITY (JP) | 2017-04-13 | — | — | US | disclosed |
| EP-2614091-A2 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | Showa Denko K.K. (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | SHOWA DENKO K.K. (JP) | 2013-03-07 | — | — | US | disclosed |
| WO-2012033227-A2 | CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER | SHOWA DENKO K.K. (JP) | 2012-03-15 | — | — | WO | disclosed |
| US-7714087-B2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20090137757-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | IMUTA JUNICHI | 2009-05-28 | — | — | US | disclosed |
| US-7393907-B2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2008-07-01 | — | — | US | disclosed |
| US-6518305-B1 | For inhibiting neuraminidases from disease- causing microorganisms, especially, influenza neuraminidase | ABBOTT LABORATORIES | 2003-02-11 | — | — | US | disclosed |
| WO-2001028979-A2 | INHIBITORS OF NEURAMINIDASES | ABBOTT LABORATORIES (US) | 2001-04-26 | — | — | WO | disclosed |
| EP-1087938-A1 | INHIBITORS OF NEURAMINIDASES | ABBOTT LABORATORIES (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999054290-A1 | INHIBITORS OF NEURAMINIDASES | ABBOTT LABORATORIES (US) | 1999-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11331656-B2 | Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis | PPOX, CYBA, CYBB | NLRP3 3828/4885ALDH1A1 1395/4885LMNA 4173/4885 |
| US-20130059993-A1 | CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX | NNMT, PPOX, DNMT1 | NLRP3 3609/4885ALDH1A1 277/4885LMNA 4080/4885 |
| US-20220161245-A1 | Compositions And Methods For Infrared-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | CYBB, CYBA, CYB5R3 | NLRP3 3557/4885ALDH1A1 714/4885LMNA 4482/4885 |
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | PPOX, CYBA, CYBB | NLRP3 3828/4885ALDH1A1 1395/4885LMNA 4173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.